Adaptive and innate immune responses in multiple sclerosis with anti-CD20 therapy: Gene expression and protein profiles

BACKGROUND: Anti-CD20 is a highly effective therapy for multiple sclerosis (MS), a disease with multiple abnormalities in function of B and T cells and innate immune cells. Anti-CD20 therapy depletes B cells, which alters antibody production and has diverse effects on B cell immunity. These changes...

Descripción completa

Detalles Bibliográficos
Autores principales: Fong, Chloe C., Spencer, Julian, Howlett-Prieto, Quentin, Feng, Xuan, Reder, Anthony T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166068/
https://www.ncbi.nlm.nih.gov/pubmed/37168665
http://dx.doi.org/10.3389/fneur.2023.1158487

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166068/
https://www.ncbi.nlm.nih.gov/pubmed/37168665
http://dx.doi.org/10.3389/fneur.2023.1158487

Ejemplares similares